A monoclonal antibody as an effective therapeutic agent in breast cancer: trastuzumab.

Rueckert, S; Ruehl, I; Kahlert, S; Konecny, G; Untch, M

Rueckert, S; Ruehl, I; Kahlert, S; Konecny, G; Untch, M.

Affiliation

Rueckert S; Department of Gynecology and Obstetrics, Klinikum Grosshadern, Ludwig-Maximilians University of Munich, Marchioninistr. 15, 81377 Munich, Germany. Sandra.Rueckert@med.uni-muenchen.de

Expert Opin Biol Ther ; 5(6): 853-66, 2005 Jun.

Article in En | MEDLINE | ID: mdl-15952915

Subject(s)

Antibodies, Monoclonal/therapeutic use; Antineoplastic Agents/therapeutic use; Breast Neoplasms/therapy; Antibodies, Monoclonal/adverse effects; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic/therapeutic use; Antineoplastic Agents/adverse effects; Antineoplastic Agents, Phytogenic/therapeutic use; Breast Neoplasms/metabolism; Breast Neoplasms/pathology; Capecitabine; Chemotherapy, Adjuvant; Deoxycytidine/analogs & derivatives; Deoxycytidine/therapeutic use; Female; Fluorouracil/analogs & derivatives; Heart Diseases/etiology; Humans; Neoadjuvant Therapy; Neoplasm Metastasis; Patient Selection; Randomized Controlled Trials as Topic; Receptor, ErbB-2/immunology; Receptor, ErbB-2/metabolism; Taxoids/therapeutic use; Trastuzumab; Vinblastine/analogs & derivatives; Vinblastine/therapeutic use; Vinorelbine

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antibodies, Monoclonal / Antineoplastic Agents Type of study: Clinical_trials / Etiology_studies Limits: Female / Humans Language: En Journal: Expert Opin Biol Ther Journal subject: BIOLOGIA / TERAPEUTICA Year: 2005 Document type: Article Affiliation country: Germany

Search on Google

Add to My VHL

XML

PubMed Links